Tilia Fiduciary Partners’s Organon & Co OGN Stock Holding History

Tilia Fiduciary Partners’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6	Closed	–	–	543
2022 Q1	$0	Hold	6	–	–	﹤0.01%	554
2021 Q4	$0	Buy	+6	New	+$195	﹤0.01%	554

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tilia Fiduciary Partners's OGN Position: Q2 2022 in Review

Tilia Fiduciary Partners sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 6 shares.

Tilia Fiduciary Partners first reported a position in OGN in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

Tilia Fiduciary Partners reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
Tilia Fiduciary Partners sold 6 Organon & Co shares in Q2 2022.
Tilia Fiduciary Partners first reported a position in Organon & Co in Q4 2021 and held it in 2 quarters.
Tilia Fiduciary Partners's Organon & Co position peaked at $0 in Q1 2022.
853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Tilia Fiduciary Partners's 13F filing for Q2 2022, filed 1 Aug 2022.